Your browser doesn't support javascript.
loading
Tetherin antagonism by SARS-CoV-2 ORF3a and spike protein enhances virus release.
Stewart, Hazel; Palmulli, Roberta; Johansen, Kristoffer H; McGovern, Naomi; Shehata, Ola M; Carnell, George W; Jackson, Hannah K; Lee, Jin S; Brown, Jonathan C; Burgoyne, Thomas; Heeney, Jonathan L; Okkenhaug, Klaus; Firth, Andrew E; Peden, Andrew A; Edgar, James R.
Afiliación
  • Stewart H; Department of Pathology, University of Cambridge, Cambridge, UK.
  • Palmulli R; Department of Pathology, University of Cambridge, Cambridge, UK.
  • Johansen KH; Department of Pathology, University of Cambridge, Cambridge, UK.
  • McGovern N; Laboratory of Immune Systems Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Shehata OM; Department of Pathology, University of Cambridge, Cambridge, UK.
  • Carnell GW; Department of Biomedical Science, University of Sheffield, Firth Court, Sheffield, UK.
  • Jackson HK; Department of Veterinary Medicine, University of Cambridge, Cambridge, UK.
  • Lee JS; Department of Pathology, University of Cambridge, Cambridge, UK.
  • Brown JC; Department of Pathology, University of Cambridge, Cambridge, UK.
  • Burgoyne T; Department of Infectious Disease, Imperial College London, London, UK.
  • Heeney JL; Royal Brompton Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Okkenhaug K; UCL Institute of Ophthalmology, University College London, London, UK.
  • Firth AE; Department of Veterinary Medicine, University of Cambridge, Cambridge, UK.
  • Peden AA; Department of Pathology, University of Cambridge, Cambridge, UK.
  • Edgar JR; Department of Pathology, University of Cambridge, Cambridge, UK.
EMBO Rep ; 24(12): e57224, 2023 Dec 06.
Article en En | MEDLINE | ID: mdl-37818801
ABSTRACT
The antiviral restriction factor, tetherin, blocks the release of several different families of enveloped viruses, including the Coronaviridae. Tetherin is an interferon-induced protein that forms parallel homodimers between the host cell and viral particles, linking viruses to the surface of infected cells and inhibiting their release. We demonstrate that SARS-CoV-2 infection causes tetherin downregulation and that tetherin depletion from cells enhances SARS-CoV-2 viral titres. We investigate the potential viral proteins involved in abrogating tetherin function and find that SARS-CoV-2 ORF3a reduces tetherin localisation within biosynthetic organelles where Coronaviruses bud, and increases tetherin localisation to late endocytic organelles via reduced retrograde recycling. We also find that expression of Spike protein causes a reduction in cellular tetherin levels. Our results confirm that tetherin acts as a host restriction factor for SARS-CoV-2 and highlight the multiple distinct mechanisms by which SARS-CoV-2 subverts tetherin function.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Liberación del Virus / Glicoproteína de la Espiga del Coronavirus / Antígeno 2 del Estroma de la Médula Ósea / SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: EMBO Rep Asunto de la revista: BIOLOGIA MOLECULAR Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Liberación del Virus / Glicoproteína de la Espiga del Coronavirus / Antígeno 2 del Estroma de la Médula Ósea / SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: EMBO Rep Asunto de la revista: BIOLOGIA MOLECULAR Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
...